# AstraZeneca Pharmaceuticals LP – FDA Inspection, Jan 30, 2018

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/c9e65f66-82de-438f-8f3b-d9031f8e55ba
Source feed: FDA_Inspections

> FDA inspection 1039113 of AstraZeneca Pharmaceuticals LP, January 30, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 314. Form 483 issued. 15 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1039113
- Company Name: AstraZeneca Pharmaceuticals LP
- Inspection Date: 2018-01-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1299436 - 2026-01-14
- [FDA Inspection 1254239 - 2024-10-25](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/da96b405-5d6f-462e-8164-cc589345ae2e)
- [FDA Inspection 1238346 - 2024-05-31](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f4d9b1b5-b5fa-492a-8363-3e39782013b0)
- FDA Inspection 1230136 - 2024-01-22
- FDA Inspection 1211604 - 2023-07-18

## Related Officers

- [Investigator](https://www.keypedia.com/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)

Company: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f2e34b74-3ef4-4f39-8f6f-41eceb3bb779

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c